Challenges in the Study of Patients with HIV Type 1 Seroconversion | Zendy

Elizabeth Connick | Zendy; Samantha MaWhinney | Zendy; Cara C. Wilson | Zendy; Thomas Campbell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Challenges in the Study of Patients with HIV Type 1 Seroconversion

Author(s) -

Elizabeth Connick,

Samantha MaWhinney,

Cara C. Wilson,

Thomas Campbell

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/429339

Subject(s) - medicine , seroconversion , human immunodeficiency virus (hiv) , virology , immunology , family medicine , medline , political science , law

within 1 and 2 years after infection, respectively, and was observed in ~7% of these persons at 5 years after infection. Low-level viremia is recognized to be correlated with long-term nonprogressive HIV infection [2]. Thus, it is an important clinical end point for studies of interventions during acute-phase and early-phase HIV infection. Nevertheless, use of lowlevel viremia to interpret the impact of treatments in nonrandomized studies of

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research